Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fermathron S versus Depomedrol for hip osteoarthritis
NL-OMON24527Phase 4Withdrawn
- Sponsor
- Medisch Centrum Leeuwarden
- Start
- Jun 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hip osteoarthritis comparing Fermathron S + lidocaine with Depomedrol + lidocaine (2 arms). Primary endpoint: Pain reduction at 6 and 12 months. Planned start Jun 2014; status: withdrawn.
02
Drugs
Fermathron Smethylprednisolonelidocaine
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on NL-OMON24527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24527.